AAAAAA

   
Results: 1-25 | 26-50 | 51-61
Results: 1-25/61
TAMOXIFEN INHIBITS VEGF-MEDIATED ANGIOGENESIS
Authors: HARMEY JH MCNAMARA DA WANG JH DONOVAN D KAY E WALSH TN BOUCHIERHAYES D
Citation: Jh. Harmey et al., TAMOXIFEN INHIBITS VEGF-MEDIATED ANGIOGENESIS, Journal of vascular research, 35(5), 1998, pp. 376-377
THE ROLE OF MRCP IN THE EVALUATION OF PATIENTS WITH ACUTE IDIOPATHIC OR GALLSTONE PANCREATITIS
Authors: VARGHESE JC SOOKHAI S MURRAY F WALSH TN OSBORNE H LEE MJ
Citation: Jc. Varghese et al., THE ROLE OF MRCP IN THE EVALUATION OF PATIENTS WITH ACUTE IDIOPATHIC OR GALLSTONE PANCREATITIS, Radiology, 209P, 1998, pp. 330-330
OMEPRAZOLE ALTERS GASTRIC-MOTILITY AS DEMONSTRATED BY ELECTROGASTROGRAPHY
Authors: MCNAMARA DA WALSH TN BOUCHIERHAYES DJ
Citation: Da. Mcnamara et al., OMEPRAZOLE ALTERS GASTRIC-MOTILITY AS DEMONSTRATED BY ELECTROGASTROGRAPHY, Gastroenterology, 114(4), 1998, pp. 3297-3297
EXPOSURE TO LIPOPOLYSACCHARIDE ELICITS VASCULAR ENDOTHELIAL GROWTH-FACTOR PRODUCTION BY MACROPHAGES AND TUMOR-CELLS
Authors: MCNAMARA DA PIDGEON G HARMEY J REDMOND HP WALSH TN BOUCHIERHAYES DJ
Citation: Da. Mcnamara et al., EXPOSURE TO LIPOPOLYSACCHARIDE ELICITS VASCULAR ENDOTHELIAL GROWTH-FACTOR PRODUCTION BY MACROPHAGES AND TUMOR-CELLS, Gastroenterology, 114(4), 1998, pp. 4761-4761
SIGNIFICANCE OF ANGIOGENESIS IN CANCER-THERAPY
Authors: MCNAMARA DA HARMEY JH WALSH TN REDMOND HP BOUCHIERHAYES DJ
Citation: Da. Mcnamara et al., SIGNIFICANCE OF ANGIOGENESIS IN CANCER-THERAPY, British Journal of Surgery, 85(8), 1998, pp. 1044-1055
IMPORTANCE OF NEGATIVE MICROSCOPIC MARGINS IN THE MULTIMODALITY THERAPY OF ESOPHAGEAL CANCER
Authors: MULLIGAN ED WALSH TN DUNNE B PURCELL T GRIFFIN M NOONAN N HOLLYWOOD D KEELING N REYNOLDS JV HENNESSY TPJ
Citation: Ed. Mulligan et al., IMPORTANCE OF NEGATIVE MICROSCOPIC MARGINS IN THE MULTIMODALITY THERAPY OF ESOPHAGEAL CANCER, British Journal of Surgery, 85(5), 1998, pp. 695-695
TUMOR LENGTH PREDICTS RESPONSE TO NEOADJUVANT CHEMORADIOTHERAPY IN ESOPHAGEAL ADENOCARCINOMA
Authors: MULLIGAN ED WALSH TN DUNNE B PURCELL T GRIFFIN M NOONAN N HOLLYWOOD D KEELING N REYNOLDS JV HENNESSY TPJ
Citation: Ed. Mulligan et al., TUMOR LENGTH PREDICTS RESPONSE TO NEOADJUVANT CHEMORADIOTHERAPY IN ESOPHAGEAL ADENOCARCINOMA, British Journal of Surgery, 85(5), 1998, pp. 696-696
LIPOPOLYSACCHARIDE-MEDIATED UP-REGULATION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR IN MACROPHAGES AND TUMOR-CELLS
Authors: MCNAMARA DA PIDGEON G HARMEY J WALSH TN REDMOND HP BOUCHIERHAYES DJ
Citation: Da. Mcnamara et al., LIPOPOLYSACCHARIDE-MEDIATED UP-REGULATION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR IN MACROPHAGES AND TUMOR-CELLS, British Journal of Surgery, 85(5), 1998, pp. 714-714
MURINE AND HUMAN MACROPHAGES RESPOND DIFFERENTLY TO LIPOPOLYSACCHARIDE
Authors: MCNAMARA DA PIDGEON G HARMEY J WALSH TN REDMOND HP BOUCHIERHAYES DJ
Citation: Da. Mcnamara et al., MURINE AND HUMAN MACROPHAGES RESPOND DIFFERENTLY TO LIPOPOLYSACCHARIDE, British Journal of Surgery, 85, 1998, pp. 110-111
TAMOXIFEN IS ANTIANGIOGENIC IN-VITRO AND ATTENUATES VASCULAR ENDOTHELIAL GROWTH FACTOR-MEDIATED ANGIOGENESIS IN-VIVO WITHOUT ADVERSE-EFFECTS ON WOUND-HEALING
Authors: MCNAMARA DA HARMEY J WANG JH DONOVAN D KAY E WALSH TN BOUCHIERHAYES DJ
Citation: Da. Mcnamara et al., TAMOXIFEN IS ANTIANGIOGENIC IN-VITRO AND ATTENUATES VASCULAR ENDOTHELIAL GROWTH FACTOR-MEDIATED ANGIOGENESIS IN-VIVO WITHOUT ADVERSE-EFFECTS ON WOUND-HEALING, British Journal of Surgery, 85(11), 1998, pp. 1556-1556
SIGNIFICANCE OF ANGIOGENESIS IN CANCER-THERAPY (VOL 85, PG 1044, 1998)
Authors: MCNAMARA DA HARMEY JH WALSH TN REDMOND HP BOUCHIERHAYES DJ
Citation: Da. Mcnamara et al., SIGNIFICANCE OF ANGIOGENESIS IN CANCER-THERAPY (VOL 85, PG 1044, 1998), British Journal of Surgery, 85(10), 1998, pp. 1449-1449
TAMOXIFEN IS ANTI-ANGIOGENIC IN-VITRO AND ATTENUATES VEGF-MEDIATED ANGIOGENESIS IN-VIVO WITHOUT ADVERSE-EFFECTS ON WOUND-HEALING
Authors: MCNAMARA DA HARMEY J WANG JH DONOVAN D KAY E WALSH TN BOUCHIERHAYES DJ
Citation: Da. Mcnamara et al., TAMOXIFEN IS ANTI-ANGIOGENIC IN-VITRO AND ATTENUATES VEGF-MEDIATED ANGIOGENESIS IN-VIVO WITHOUT ADVERSE-EFFECTS ON WOUND-HEALING, British Journal of Cancer, 78, 1998, pp. 28-28
SMALL-CELL CARCINOMA OF THE ESOPHAGUS
Authors: POYNTON AR WALSH TN KELLY A HARNEY M STUART R DALY PA HENNESSY TPJ
Citation: Ar. Poynton et al., SMALL-CELL CARCINOMA OF THE ESOPHAGUS, European journal of surgical oncology, 23(6), 1997, pp. 509-512
MULTIMODAL THERAPY FOR ESOPHAGEAL ADENOCARCINOMA - REPLY
Authors: WALSH TN KELLY A HENNESSY TPJ
Citation: Tn. Walsh et al., MULTIMODAL THERAPY FOR ESOPHAGEAL ADENOCARCINOMA - REPLY, The New England journal of medicine, 336(5), 1997, pp. 375-376
DELAY IN TREATMENT FOR ESOPHAGEAL CANCER
Authors: ROTHWELL JF FEEHAN E REID I WALSH TN HENNESSY TPJ
Citation: Jf. Rothwell et al., DELAY IN TREATMENT FOR ESOPHAGEAL CANCER, British Journal of Surgery, 84(5), 1997, pp. 690-693
CHOLECYSTECTOMY-INDUCED GASTROESOPHAGEAL REFLUX - IS IT REDUCED BY THE LAPAROSCOPIC APPROACH
Authors: ROTHWELL JF LAWLOR P BYRNE PJ WALSH TN HENNESSY TPJ
Citation: Jf. Rothwell et al., CHOLECYSTECTOMY-INDUCED GASTROESOPHAGEAL REFLUX - IS IT REDUCED BY THE LAPAROSCOPIC APPROACH, The American journal of gastroenterology, 92(8), 1997, pp. 1351-1354
A COMPARISON OF MULTIMODAL THERAPY AND SURGERY FOR ESOPHAGEAL ADENOCARCINOMA
Authors: WALSH TN NOONAN N HOLLYWOOD D KELLY A KEELING N HENNESSY TPJ
Citation: Tn. Walsh et al., A COMPARISON OF MULTIMODAL THERAPY AND SURGERY FOR ESOPHAGEAL ADENOCARCINOMA, The New England journal of medicine, 335(7), 1996, pp. 462-467
ESOPHAGEAL BILE REFLUX IN BARRETTS-ESOPHAGUS
Authors: CALDWELL MTP MACKAY CK STUART RC WALSH TN BAXTER JN BYRNE PJ HENNESSY TPJ
Citation: Mtp. Caldwell et al., ESOPHAGEAL BILE REFLUX IN BARRETTS-ESOPHAGUS, Gastroenterology, 110(4), 1996, pp. 73-73
ALKALINE PH SHIFT IN THE STOMACH AND ESOPHAGUS DOES NOT PREDICT ESOPHAGEAL BILE REFLUX
Authors: CALDWELL MTP LAWLOR P BYRNE PJ WALSH TN HENNESSY TPJ
Citation: Mtp. Caldwell et al., ALKALINE PH SHIFT IN THE STOMACH AND ESOPHAGUS DOES NOT PREDICT ESOPHAGEAL BILE REFLUX, Gastroenterology, 110(4), 1996, pp. 73-73
ANTIREFLUX SURGERY - ITS ROLE IN BILE REFLUX
Authors: FLAHERTY J LAWLOR P BYRNE PJ WALSH TN HENNESSY TPJ
Citation: J. Flaherty et al., ANTIREFLUX SURGERY - ITS ROLE IN BILE REFLUX, Gastroenterology, 110(4), 1996, pp. 108-108
THE BILITEC PROBE IN THE ASSESSMENT OF PATIENTS FOR REVISIONAL GASTRIC-SURGERY
Authors: MACKAY CK CALDWELL MTP STUART RC WALSH TN BAXTER JN CARTER R BYRNE PJ HENNESSY TPJ
Citation: Ck. Mackay et al., THE BILITEC PROBE IN THE ASSESSMENT OF PATIENTS FOR REVISIONAL GASTRIC-SURGERY, Gastroenterology, 110(4), 1996, pp. 182-182
ESOPHAGEAL BILE AND ACID REFLUX INCREASES FOLLOWING CHOLECYSTECTOMY
Authors: CALDWELL MTP ROTHWELL J LAWLOR P BYRNE PJ WALSH TN HENNESSY TPJ
Citation: Mtp. Caldwell et al., ESOPHAGEAL BILE AND ACID REFLUX INCREASES FOLLOWING CHOLECYSTECTOMY, Gastroenterology, 110(4), 1996, pp. 449-449
CHOLECYSTECTOMY-INDUCED GASTROESOPHAGEAL REFLUX - IS IT REDUCED BY THE LAPAROSCOPIC APPROACH
Authors: ROTHWELL J CALDWELL MTP LAWLOR P BYRNE PJ WALSH TN HENNESSY TPJ
Citation: J. Rothwell et al., CHOLECYSTECTOMY-INDUCED GASTROESOPHAGEAL REFLUX - IS IT REDUCED BY THE LAPAROSCOPIC APPROACH, Gastroenterology, 110(4), 1996, pp. 475-475
DELAY IN TREATMENT FOR ESOPHAGEAL CANCER
Authors: ROTHWELL J FEEHAN E REID I WALSH TN HENNESSY TPJ
Citation: J. Rothwell et al., DELAY IN TREATMENT FOR ESOPHAGEAL CANCER, Gastroenterology, 110(4), 1996, pp. 584-584
MULTIMODALITY THERAPY VERSUS SURGERY FOR ESOPHAGEAL ADENOCARCINOMA - A PROSPECTIVE RANDOMIZED TRIAL
Authors: WALSH TN NOONAN N HOLLYWOOD D KELLY A KEELING PNW HENNESSY TPJ
Citation: Tn. Walsh et al., MULTIMODALITY THERAPY VERSUS SURGERY FOR ESOPHAGEAL ADENOCARCINOMA - A PROSPECTIVE RANDOMIZED TRIAL, Gastroenterology, 110(4), 1996, pp. 611-611
Risultati: 1-25 | 26-50 | 51-61